Federal Circuit Vacates PTAB’s Inter Partes Review Decision That Concluded a Petitioner Failed to Prove Claims Would Have Been Obvious

Nov 18, 2015

Reading Time : 1 min

In two separate IPR petitions Ariosa alleged that all claims of Verinata’s patent would have been obvious in 2010 based on three prior-art references. The PTAB instituted review but ultimately found that Ariosa failed to carry its burden to prove invalidity. Among other things, the Board criticized a second declaration that Ariosa submitted, which relied on a brochure that described nucleotide sequencing using a commercially available instrument. The Board stated:

This testimony, in effect, replaces [teachings of two of the cited references] with [teachings of the brochure], but neither Petitioner nor [the declarant] explains why [the brochure] could not have been presented as part of the asserted ground of unpatentability in the first instance with the Petition. Therefore we accord this aspect of [the declarant’s] testimony no weight. (emphasis added)

The Federal Circuit noted that Ariosa’s Petitions and opening declarations cited the brochure to explain the knowledge of skilled artisans at the time. The Court found the PTAB’s decision unclear as to whether the PTAB had refused to consider the brochure for any reason at all, including for what it showed about the background knowledge of a skilled artisan, which would have been legal error. Thus, the Court vacated and remanded for clarification, specifically noting that the PTAB need not take new evidence or even accept new briefing; it was free to control the proceeding on remand as it saw fit to address the Court’s concern.

Ariosa had also challenged the PTAB’s refusal to consider portions of one of the prior-art references that the PTAB found Ariosa had cited only in its Reply submissions. The Federal Circuit found no error in the PTAB’s “rejection of Ariosa’s reliance, it its Reply submissions, on previously unidentified portions of a prior-art reference to make a meaningfully distinct contention.”

Ariosa Diagnostics v. Verinata Health, Inc., Nos. 15-1215; -1226 (Fed. Cir. Nov. 16, 2015)

Share This Insight

Previous Entries

IP Newsflash

May 30, 2025

A district court recently dismissed a patent infringement complaint for improper venue under 28 U.S.C. § 1400(b), finding that the storage and distribution of products from an Amazon warehouse was not sufficient to establish that warehouse as a regular and established place of business in the district.

...

Read More

IP Newsflash

May 27, 2025

The Federal Circuit affirmed a District of Delaware finding of non-infringement in an ANDA litigation due to the patentee’s clear and unmistakable disavowal of claim scope during prosecution. Specifically, the court held that statements made during prosecution of a parent application before the asserted claims were allowed amounted to a prosecution disclaimer that extended to subsequent patents in the family. In reaching this conclusion, the court rejected an attempt by the patentee to resurrect the claim scope through a unilateral, self-serving statement made in later applications in the family.

...

Read More

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and the related statutory context.

...

Read More

IP Newsflash

May 12, 2025

The Patent Trial and Appeal Board recently declined to institute a petition for IPR that was filed on the same day that the petitioner filed another petition challenging the same claims of the same patent. The board was not persuaded by petitioner’s arguments that a second petition was needed due to alleged claim construction issues or the number, length or scope differences of the challenged claims.

...

Read More

IP Newsflash

May 9, 2025

The USPTO Director vacated the board’s decision to institute inter partes review based on an erroneous application of the Fintiv factors. Specifically, the Director found that the board placed too much emphasis on Petitioner’s Sotera stipulation, and not enough emphasis on the investment in the parallel litigation. Weighing the factors as a whole, the Director determined that institution should be denied.

...

Read More

IP Newsflash

May 9, 2025

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.

...

Read More

IP Newsflash

April 23, 2025

The Federal Circuit recently refused to apply collateral estoppel to claims of a patent asserted in district court litigation based on a Patent Trial and Appeal Board (PTAB) decision finding similar claims from the same patent unpatentable because the PTAB applied a lower burden of proof than what is required to invalidate claims in district court.

...

Read More

IP Newsflash

April 7, 2025

The Central District of California denied a defendant’s motion to dismiss or transfer plaintiff’s first-filed declaratory judgment action based on defendant’s later-filed patent infringement suit in Wisconsin.  Though suit was seemingly imminent when defendant advised plaintiff it might be infringing defendant’s patents, plaintiff responded by requesting a licensing agreement in lieu of litigation. The court found that plaintiff’s action was not anticipatory forum-shopping litigation because plaintiff only filed suit after defendant neglected to respond to its licensing offer.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.